Advances in the Treatment of Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma

Article

Related Videos
Craig Moskowitz, MD
Richard J. Lin, MD, PhD
Jason Westin, MD, FACP
Sarah Sammons, MD
Laura Spring, MD
Laura Spring, MD
Corey J. Langer, MD
John F. Lazar, MD
Rodolfo Bordoni, MD
Related Content
Expanding Horizons: Antibody-Drug Conjugates in Non–Small Cell Lung Cancer

Expanding Horizons: Antibody-Drug Conjugates in Non–Small Cell Lung Cancer

April 21st 2023
Article
Clinical Decision Making in Advanced NSCLC without Actionable Mutations

Clinical Decision Making in Advanced NSCLC without Actionable Mutations

April 21st 2023
Article
BTK Inhibitors in MCL and CLL

BTK Inhibitors in MCL and CLL

March 10th 2023
Article
Where Do ADCs Fit Into the Treatment Paradigm for Patients With NSCLC?

Where Do ADCs Fit Into the Treatment Paradigm for Patients With NSCLC?

January 25th 2023
Article
Clinical Case Scenarios: Approaches to Treatment Decisions in Non-Small Cell Lung Cancer

Clinical Case Scenarios: Approaches to Treatment Decisions in Non-Small Cell Lung Cancer

January 25th 2023
Article
Best Practices on Addressing Disparities and Practicing Multicultural Care in Myeloma

Best Practices on Addressing Disparities and Practicing Multicultural Care in Myeloma

December 12th 2022
Article